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1 Background
Deoxyribonucleic Acid, DNA, is the hereditary foundation of all living organisms with the primary
location being in the nucleus of the organism’s cells. Each cell in the human body contains the same
DNA which is found on chromosomes. Chromosomes are the storage of human’s genetic blueprints
that make up everything in the body. This is done through cell division. Cell division replaces old
cells with new ones with the new ones containing the same DNA as its parent cell. This is ensured
by the chromosomes that ensure the DNA is accurately copied and distributed. On rare occasions,
however, the DNA can be incorrectly copied.
Every human possesses a total of twenty-four chromosomes with each containing specific “instruc-
tions” on developing the human body. From human to human, 99% of the three billion bases that
make up the DNA are the same. Therefore, it is apparent to scientists to see what each chromosome
is responsible for in a human being. More specifically, they are able to identify the chromosome
that certain diseases can stem. For example, chromosome 1 is linked to the following diseases being
encoded in human beings: gaucher, prostate cancer, alzheimer, and glaucoma.
The structure of DNA is two strands, one sugar and one phosphate molecule, that spirals and is
connected by multiple amino acid bases. There are four amino acid bases, guanine, adenine, cyto-
sine, and thymine, notated as G, A, C, and T. The amino acid bases link to a phosphate group of
the strand and form the basic structural unit of DNA known as nucleotide. These amino acid bases
connect to one another by forming in two combinations or what is known as base pairs: adenine
pairs with thymine and guanine pairs with cytosine. The way that these base pairs organize is
known as genetic code. This order of the bases provides specific information for either creation
or maintenance of an organism. The way genetic code works is similar to how letters are used to
form different words. As previously mentioned, there are more than three billion DNA base pairs in
humans. This complete set of DNA is known as a genome. The information in a human’s genome
is everything needed to create and maintain people.
Although these are the general rules of DNA, alterations of the most common DNA nucleotide
sequences are possible. This is known as genetic variation. These alterations can be described as
benign, pathogenic, or unknown when comparing the DNA sequence to that of the Genome Ref-
erence Consortium’s DNA sequence. The way a person’s DNA sequence can acquire this variation
is due to one of the following five reasons: single nucleotide polymorphism, insertions, deletions,
substitutions, or structural variants. The main DNA sequence variation that will be of note is single
nucleotide polymorphism, or SNPs. SNPs are positions in a person’s genome where if compared to
the same location of another person’s genome, then the nucleotide differ. For instance, one person
may have a guanine nucleotide where the general population has a cytosine nucleotide. To extend
this further, say that 95% of the general population has this cytosine nucleotide at this particular
point. Then a total of 5% of individuals have this DNA variation of a guanine nucleotide in the same
location. With roughly ten million Some of these SNPs attribute to physical differences among the
population and others can affect how an individual develops diseases.
The overall impact of genetic variations on the traits of an individual is measurable. This is what
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is known as trait heritability, h2. Trait heritability is a statistical concept that takes a given trait
and tells the overall significance the genetic variation contributes to it. The range of trait heritabil-
ity is from zero to one with zero meaning that most of the variability in a trait is at the cost of
environmental factors and little influence from genetics. On the opposite side, being closer to one
indicates that genetics play a substantial role in a trait’s variability. This range is continuous and,
therefore, can result in complex traits having a heritability of 0.5. This indicates that the trait is
influenced by both environmental factors and genetics.
The Genome Wide Association Study, or GWAS, used this concept of heritability and began an
observational study on genetic variants to uncover if certain variants in an individual are associated
with a trait. One of the primary focuses of this study was on the relationship between single-
nucleotide polymorphisms and major human diseases. Ultimately, GWAS was able to validate a
relationship between human diseases and SNPs by focusing on the association of common variants
with that of major diseases. A common genetic variant is has a minor allele frequency greater than
5%. GWAS was only able to conduct single variant tests on common genetic variants due to the
astronomical prices of genetic testing back in the day. Had they been able to conduct tests with
more that ten or so genomes at the time, they might have been able to focus on the role of rare
gene variants in human diseases. However, this was not the case and the major role rare genetic
variations played would not be discovered until years after. Therefore, GWAS focused on common
genetic variants and concluded that SNPs were linked to that of human diseases. Another limitation
to GWAS was with their heritability. The role of the genetic variance played in a varying trait is a
central part of GWAS observational study. However, the heritability was often much less than 0.1.
This means that the variation of the trait was caused more by environmental factors than genetic
variation.
In the past decade, the cost to sequence a genome has dropped from almost one-hundred million
dollars to one-thousand dollars. This has allowed for studies of the genome to branch out and
focus on more niche genetic topics. One such topic that grew in popularity was that of rare genetic
variations. A rare genetic variation is one that has a minor allele frequency below 5%. This popu-
larity was due to two main factors: sample sizes of genetic testing could be larger because studies
no longer required large funds to operate them and because rare genetic variations are the major
contributors to an individual’s genetic vulnerability to major diseases. Thus, this gave way to the
Rare Variant Association Studies. However, there are certain challenges and limitations that face
the Rare Variant Association Studies. First being that single variant tests of the association have
very low power due to the fact that a small number of people carry a given rare variant allele. In
addition, a given genetic variation in the same gene can have one of the following outcomes: no
effect, different effects, or even opposite effect. With these given biological challenges, there is a
need for a robust and accurate statistical model that groups the variants and does a region-based
test. Thus, this began the development of methods: the Burden test and the Sequence Kernel
Association Test. However, these statistical tests did not test for multiple traits at the same time.
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2 Existing Methods
There is a growing literature on analyzing the association of a set of rare variants, and most of them
can be partitioned into three categories: the burden type of tests, the variance component type of
tests, and the omnibus tests.
A natural approach of set-based rare variants association test is to create a new variable that
counts the number of risk alleles an individual carries for the set and test whether this new variable
is associated with phenotypic variation. These tests, sometimes called burden tests (Morgenthaler
and Thilly, 2007; Li and Leal, 2008), are motivated by population genetics evolutionary theory that
most rare missense alleles are deleterious, and the effect is therefore generally considered one-sided
(Kryukov et al., 2007). This type of tests have simple model(model (1)) and it is obviously that this
collapsed variable can be incorporated into a regression model to account for potential confounders
(Morris and Zeggini, 2010).
Y = α + β
p∑
j=1
Gj + ε (1)
In addition, this simple count of risk alleles can also be extended to a weighted sum, where the
weight may be the frequency of rare allele in the unaffected subjects (Madsen and Browning, 2009).
However, it is also easy to see that burden tests have big limitations on strong assumption about
the same direction/magitude of genetic effects, and tend to lose power when only a small proportion
of rare variants in the set is truly causal.
Another approach to testing the association of a set of rare variants is to use the mixed effect
model framework. In this framework, the effects of variants are assumed to be independently and
identically distributed with a mean 0 and variance τ 2. That is, in model (2), assuming βi’s are
independently following N(µ, τ 2) distribution. To test whether a set of variants is associated with
the phenotype, it is equivalent to test whether the variance component τ 2 = 0. Among this variance
component type of tests, the sequence kernel association test (SKAT) (Wu et al., 2011) is the most
popular one (model (2)).
Y = α + β1G1 + β2G2 + . . .+ βpGp + ε, (2)
where the effect for the jth variant
βj
iid∼ (µ, τ 2). (3)
SKAT is powerful when there is a large number of non-causal variants, and/or both protective
and deleterious variants are present. However, it may suffer from inflated type I error under some
scenarios (Konigorski et al., 2017; Zhang et al., 2019).
Burden type of tests are more powerful when a large fraction of variants are causal and effects are
in the same direction; while the variance component type of tests are more powerful when a small
fraction of variants are causal, or the effects have mixed directions. However, both scenarios can
happen in real world when scanning the genome. Hence, researchers began to develop omnibus
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tests, i.e. combining burden tests and variance component tests, to achieve more robust power
under various scenarios. The ways of combining two types of tests include combining two p-values
(Derkach A et al., 2013), or combining two test statistics (Lee et al., 2012) obtained from burden
and variance component tests.
By assuming the variant effects following an independently and identically distribution with mean
µ and variance τ 2, where µ depends on the characteristics of genetic variants, a Mixed effects Score
Test (MiST) was proposed by Sun et al., 2013, and was shown to be a combination of burden test
and SKAT(model (3)).
Yi = α0 +Xα1 +Gβ + ε, (4)
with
βj = zjπ + δj, (5)
where
δj
iid∼ (0, τ 2). (6)
Here zj is a vector contains q characteristics of the j
th variant. These characteristics can be any
genetic score of a particular variant, or an indicator to denote the property of a variant, such as
missense or nonsense mutation. By adding a second level of model to the variant effect βj, unlike
SKAT method, MiST assumes the variant effects are random but with a mean depending on the
variant characteristics. Hence, to test whether the variant effect β is zero, it is equivalent to test
the mean, zπ, and variance component, τ 2, are zeros simultaneous. That is, the null hypothesis in
MiST method is
H0 : π = 0 and τ
2 = 0, (7)
which can be further divided into two sub null hypotheses:
H10 : τ
2 = 0 and H20 : π = 0 | τ 2 = 0 (8)
This two step hypothesis has the advantage of not requiring estimations of π and τ 2 under H1, which
is typically a difficult issue. Similar to other omnibus tests, MiST is valid, robust and powerful under
different scenarios of genome scan. However, because it includes the variance component type of
tests, it is expected also having similar limitations as SKAT, such as the inflated type I error. Some
preliminary simulation studies have shown that when the continuous phenotypic trait departures
from normal distribution, then MiST tends to have inflated type I error, especially when test
significance is stringent. Hence, in this proposal, we propose to develop a modified MiST method
based on computation permutations to control the potential type I error inflation.
3 Proposed Method
One pros of the MiST is that it can calculate p-value analytically so that to reduce the computation
cost, which, otherwise, could be huge for an implement genome-widely. However, this analytical
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p-value is obtained based on several approximations related with normal distribution. Hence, when
the traits are not closed to normal distributions, the approximation could get worse and result the
inflated type I error.
Therefore, there is a need to improve MiST so that it can control type I error well. One possible way
to solve the issue with type I error is by using a permutation based computing method. Suppose
there is n = 1000 individuals and for each of these individuals it is possible to observe the trait, Yi,
covariate Xi, and the genotype Gi, for i = 1, 2, . . . , 1000. This is demonstrated in Table 1.
Table 1: Original Data Set
Y1 X1 G1
Y2 X2 G2
Y3 X3 G3
...
...
...
Y1000 X1000 G1000
If there is no relationship between Y and G, then there should not exist the relationship between
Y and G either after their nature order was broken. For example, in Table 2, where we break the
original order between (Yi, Xi) and Gi, then we should expect that there is no relationship between
Y and G under this new order, if we assuming no such association exist under the original order.
The reason that Y and X are kept together is due to the fact that there may exist an association.
Therefore, this association requires Y and X to be together.
Table 2: Permutated Data Set
Y103 X103 G1
Y72 X72 G2
Y546 X546 G3
...
...
...
Y389 X389 G1000
If the original data sets contains n individuals, then it is possible to obtain n! permutated data sets.
For each of these permutated data sets, MiST calculates two tests statistic, Sjτ and S
j
π, to test the
two hypotheses proposed in model (4). Suppose the corresponding test statistics calculated under
the original data set are denoted as, S0τ and S
0
π. Using the definition of p-values, the permutated
p-values, pτ and pπ, for two hypotheses are calculated as the proportions of S
j
τ ≥ S0τ and Sjπ ≥ S0π,
where j = 1, 2, ..., n!.
p− value = # of Sj ≥ S0
n!
, j = 1, 2, . . . , n!
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In addition, in order to test two hypotheses simultaneously, we need to combine two permutated
p-values, pτ and pπ, in to an overall p-value. Here, we proposed to use Fisher’s combination method.
Let
q = −2× {ln pτ + ln pπ}, (9)
then q ∼ χ2(4) approximately. Therefore, poverall can be calculated as
poverall = P (χ
2(4) > q) . (10)
In reality, since the sample size n is usually large, it is impossible to do the full permutation, i.e.
n! permutated data sets. Hence, we can choose to generate P permutated data sets for each of N
available data sets. Consequently, for each of the N data sets, a permutated overall p-value, pi or
poverall, for i = 1, 2, . . . , N , is obtained. The empirical type I error is then calculated the following
way
P (type I error) =
# of pi < α
N
, i = 1, 2, . . . , N (11)
That is, the final empirical type I error rate is the number of p-values less than the test significance
level, α, divided by N , the number of data sets.
4 Simulation Studies
To investigate the performance of proposed permutation test method, we did multiple simulation
studies under various scenarios, by running MiST package through R studio. Particularly, our
simulation studies focus on the type I error rate by comparing empirical false discover rate under
different distributions for model error.
In the simulations, we generated the data sets by using t(3), and Gamma(5, 1)−5, as model errors,
respectively, and compared the emprical type I error rate when significance level, alpha equals 0.05
and 0.01. The reason we choose these two distributions for the model error is because we want to
check the performance of the proposed permutation method when the error doesn’t follow a normal
distribution, which is an ideal scenario. Particularly, t-distribution is as symmetric as normal but
having longer tails than normal, and Gamma distribution is skewed compared with normal (Figure
1).
Since the focus of the simulations is on the inflated type I error, the data sets generated must be
done so under the null model. This means that Y is a response generated from the model (12)
Yn×1 = Xn×mαm×1 + εn×1 (12)
In the simulation study the sample size n equals 1000, and we consider two covariates in the null
model. Hence, in the null model (12), the covariate matrix X contains 3 columns, where the first
column represents for intercept and the remaining two columns represent for two covariate vari-
ables. The second column of X is generated from the Uniform(10, 50) and represents a continuous
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Figure 1: Density Curve Plot
covariate. The third column of X is generated from Bernoulli(0.5) distribution and accounts for a
binary covariate. In addition, the coefficient alpha in the null model is equal to a vector of (0.5, 1, 1)
for the intercept and the effects of two covariate variables. For the model error, ε, it is generated
from one of two distributions. The first one is the t-distribution, t(3), which is symmetric with
a heavier tail compared to the normal distribution. The second distribution is Gamma(5, 1) − 5.
Gamma is skewed and by minus 5, it has a mean of 0, similar to the t and the ideal scenario,
standard normal distribution. Taking all this information, Y is generated by plugging in X, α, and
ε into the null model (12).
When using the MiST package, it is paramount to provide the genotype matrix, Gn×p as well as
the matrix of the characteristic, Zp×v, where p is the number of genetic variants, and v is the
number of variant characteristics. Therefore, G and Z must be generated before simulations. In the
simulation study, we designed to use a real world data set from the Dallas Heart Study (Victor et al.,
2004) as the genotype matrix G, in order to mimic the realistic complexity among genetic variants.
Specifically in the simulation study, the genotype data of 50 rare variants from gene ANGPTL5
from 1000 individuals was used as the genotype matrix G. For simplicity, the variant characteristic
matrix Z was set to be a vector of length 50 with all the elements as 1’s. Finally, we generated
N = 1000 data sets, and for each data set, run P = 2000 permutations. The simulation results are
summarized in Table 3.
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Table 3: Empirical Type I Error Rates
Permutation method MiST
t(3) Gamma(5, 1)− 5 t(3) Gamma(5, 1)− 5
α = 0.01 0.057 0.061 0.058 0.057
α = 0.01 0.015 0.013 0.017 0.013
In addition, in Table 3, we also list the empirical type I error rate by using the original MiST
package directly on the same N = 1000 data sets without permutations. From the comparison
between the proposed permutation method and the original MiST method, we can see that the
permutation method improves the type I error rate when the model error follows a t-distribution,
epically when the significant level is small. When α = 0.01, the type I error rate of the permutation
method for t(3) is 0.015, which is smaller than 0.017, the one obtained by using MiST directly.
There is also slightly decrease of type I error rate for t(3), when α = 0.05 by using the permutated
method. However such improvement is so obvious when model error follows a gamma distribution,
and further research is needed for the potential reason.
5 Discussion
To sum up, a modified MiST, where the p-value is obtained empirically by permutating test statis-
tics to avoid approximation related with normal distribution, is used in this project. To eliminate
potential large computation burden from permutations, we can propose to use a two-step permu-
tation. That is, MiST permutates limited times in the first step for the purpose of scanning, and
then only does extensive permutations for the candidate regions obtain from the first step. For the
simulations, large simulation studies are used to check the performance of the proposed modified
MiST method, especially in the view of controlling type I error under various scenarios, and the
simulation studies show that the proposed permutation method helps to improve the control of type
I error under some circumstance, especially when the significance level alpha is small.
Since in the genetic association study, people usually use more stringent significance level than 0.05
or 0.01 due the large number of genetic variants, it is worth to conduct further investigations on
the performance of permutated method when alpha is as small as 10−3 or 10−4.
In addition, the current permutation method is time consuming because of the needs for large
numbers of permutations. For example, in order to run the simulation for one distribution, it would
take about two days. Hence, possible future works could modify the current permutation testing in
order to decrease the computation burden.
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